Iontophoresis of nafarelin across human skin in vitro.
Iontophoresis of nafarelin across human skin in vitro.
复制标题
那法瑞林在体外穿过人体皮肤的离子电渗疗法。
DOI:
10.1023/a:1016072205371
复制
发表时间:
1996
影响因子:
3.7
通讯作者:
Guy,RH
中科院分区:
文献类型:
--
作者:
RodríguezBayón,AM;Guy,RH
Due to proteolytic enzymes in the gastro—intestinal tract and extensive “first-pass” hepatic metabolism, proteins and peptides are not usually active following oral administration. However, other routes of drug delivery, including transdermal, provide the possibility of avoiding the hepato-gastrointestinal “first-pass” elimination and of better patient compliance (1). Because peptides and proteins have large molecular weights, are mostly hydrophilic and are often charged, their passive transdermal delivery is impossible, and an enhancement strategy is therefore essential. Iontophoresis, which employs an electri-cal potential gradient to drive substances through the skin, represents one approach to increase the skin’s permeability (1—3).Nafarelin is a decapeptide analog of leutinizing hormone releasing hormone (LHRH). It is a potent superagonist and has several physiological effects in both females and males (4, 5). The anodal iontophoresis of Nafarelin across both human and hairless mouse skin (hms) has been demonstrated (6, 7). Detailed study of its electrotransport through hms has revealed that the mechanism of enhanced delivery is primarily via electroosmosis; however, the peptide associates strongly with the skin’s net negative charge, effectively neutralizing this property, and thereby inhibiting its own permeation (6—8). It has been shown that electroosmotic flow across hms (in the normal anodal-to-cathodal direction) can be reduced by a factor of ten due to the anodal iontophoresis of Nafarelin (8). The effect is dependent upon the concentration of Nafarelin in the donor chamber, becoming more important with increasing concentration (7).